Eli Lilly

MannKind: The Postmortem Is Available

With no positive trajectory, no incredible opportunity, and no significant growth tells the story of MannKind's future.<p>Three years of direct …

Business

Uncertain Inheritance: Epigenetics and the Poisoning of Michigan

In 1973, a toxic chemical was mixed into tons of farm feed, sickening livestock and exposing millions of Michiganders. Should later generations worry?<p>…

Science

In Election Year, Drug Industry Spent Big To Temper Talk About High Drug Prices

Support the news<p>Facing bipartisan hostility over high drug prices in an election year, the pharmaceutical industry's biggest trade group boosted …

Health Care

I still have a few questions

I’m sure you’ve heard by now that the Trump administration has informed the CDC that they’re no longer allowed to use the words “vulnerable,” …

Alex Azar

Lawmakers zero in on next target in fight against high drug prices

Both Republican and Democratic senators have criticized moves by drug makers to extend the life of their monopolies on sales. But action on high drug …

Pharma

How is health tech addressing the demand for cheaper prescription drugs?

GoodRx, for example, developed a skill for Amazon’s Alexa to track down cheap prescription drugs.

Medical Technology

When the Cure Is the Cause: The Case of the Green Hairy Tongue

Too often, a medical treatment can make matters worse. A bizarre epidemic in 1960s Japan should have set off alarms around the world.<p>Keiko …

Medicine

Pfizer takes on Novartis, Lilly with Xeljanz psoriatic arthritis approval

For the second straight week, there’s a new psoriatic arthritis drug on the block. This week, that drug is Pfizer’s Xeljanz, which nabbed an FDA …

Pharma

Out Walked Monk

Photo by Nick Lee | CC BY 2.0Usually Monk walked. He ambled across the city on feet as light as a tap-dancer. He weaved his way down block after …

Jazz

Big Pharma And Biotech Companies Are Girding For A 2018 Drug Price War | Stock News & Stock Market Analysis - IBD

Invest in the disruptors.<p>That's the advice from Wall Street, as giant biotech companies and the incumbents of Big Pharma are bracing to get crushed …

Pharma

European advisory group backs Lilly's Taltz for psoriatic arthritis; shares up 1%

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopts a positive opinion recommending approval for Eli Lilly's …

Business

Novo Nordisk wins EU panel's backing for key diabetes drug

COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, its biggest growth prospect, when a European Medicines Agency (EMA) experts' panel issued a positive recommendation on Friday.<p>The once-weekly injection, known generically as …

Diabetes

Cramer's lightning round: Buy Regeneron, it's not getting the credit it deserves

Regeneron: "Buy, buy, buy! That company, I think, is doing great things and not getting the credit for it. [CEO] Len Schleifer's doing remarkable …

Stocks

Aratana's stem cell candidate AT-016 flunks osteoarthritis study in dogs, further development uncertain

Pet med developer Aratana Therapeutics (NASDAQ:PETX) announces that a study evaluating allogeneic stem cell therapy AT-016 for the treatment of …

Business

Careers 2018: Growing your own talent is best way to ensure quality pipeline

To create a pipeline of new talent, recruit the right candidates and develop future team leads, Fastnet — The Talent Group has launched a unique …

News (Ireland)

Your Daily Pharma Scoop: Conatus Looks Undervalued, Teva Announces Restructuring, Bristol-Myers Signs Licensing Agreement

Conatus is a promising player in the NASH space, trading at a discount.<p>Teva announced a workforce reduction and other cost-cutting …

Stocks

Chi-Med initiates Fruquintinib U.S. clinical trials

Hutchison China MediTech Limited (“Chi-Med”) (NASDAQ:HCM) has initiated the U.S. Phase I bridging clinical trial of fruquintinib.<p>The study is a …

Medicine

Bumper crop of new drugs fails to lift big pharma R&D returns

LONDON (Reuters) - It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.<p>In fact, projected returns at 12 of the world's top drugmakers have …

Pharma

Investors, Here's Your Big Chance: Cramer's 'Mad Money' Recap (Thurs 12/14/17)

Did you see today's market weakness as a buying opportunity? Jim Cramer told his <i>Mad Money</i> viewers Thursday that he hopes they did, because there are …

Stocks

Eli Lilly office block will add capacity for 500 new jobs in Cork

US pharmaceutical giant Eli Lilly is set to add capacity for about 500 new jobs in Cork.<p>The company has signed contracts for a new €20m office …

News (Ireland)

LUNCHTIME BULLETIN: Woman charged in connection with Mulhuddart shooting, Controversial Republican refusing to concede defeat

Your lunchtime news bulletin.<p>GET INFORMED ...<p><b>IRELAND:</b> A 23-year-old woman has appeared in court charged in connection with a shooting in west Dublin …

News (Ireland)

Why Consulting Can Be Better Than Retiring

By 2011, at age 53, Warren Dodge was primed for retirement. He had spent 29 years at Accenture as an information technology and change management …

U.S. Food and Drug Administration

The missing Alzheimer's pill

When it comes to some of the biggest diseases America faces in the future, our drug system is set up to fail. What needs to happen?<p>If there’s a dream of what a new drug is supposed to do, it might look something like Kalydeco. In 2012, the new light-blue pill from Vertex Pharmaceuticals rocked the …

Long-form Journalism

Big Pharma Is Urged to Report on Links Between Pricing and Pay

Pharmaceutical companies should be required to regularly report whether there’s a link between drug-pricing strategies and executive-compensation …

Business

Industrial stocks drive Wall Street higher; Fed decision eyed | Reuters

(Reuters) - A surge in shares of Caterpillar and Boeing lifted the Dow industrials to record level in early afternoon trading on Wednesday, ahead of …

Markets

Eli Lilly builds $23B-plus sales forecast on diabetes, cancer launches

Eli Lilly is betting that its new drugs will kick off an era of growth, but the company will have to contend with a tough environment in diabetes and …

Pharma

Why Biotech Sage Therapeutics May Keep Soaring | Investopedia

<i>(Note: The author of this fundamental analysis is a financial writer and portfolio manager.)</i><p>Sage Therapeutics Inc. (SAGE) has been on fire lately, …

Finance

Eli Lilly: Updated Guidance Is a Shot in the Arm

Shares of <b>Eli Lilly</b> (LLY) are climbing on Wednesday, after the drug maker's updated guidance for this year and next.<p>Eli Lilly said that it expects to …

Markets

The Biggest Moments of 2017 in the Fight for Universal Healthcare

In the face of a fiercely conservative administration, 2017 has seen an upsurge in popular resistance against measures that threatened to chip away …

Health Care

Latest Student Loan Debacle Is Ultimate Example of Trump's Campaign Con

The president ran against debt predators, drug makers and big banks – once elected, he immediately got in bed with all of them<p>Last October, just …

U.S. Politics